Author
Listed:
- Christian Bär
(Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO))
- Bruno Bernardes de Jesus
(Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO))
- Rosa Serrano
(Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO))
- Agueda Tejera
(Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO))
- Eduard Ayuso
(Centre of Animal Biotechnology and Gene Therapy (CBATEG), School of Veterinary Medicine, Universitat Autònoma de Barcelona)
- Veronica Jimenez
(Centre of Animal Biotechnology and Gene Therapy (CBATEG), School of Veterinary Medicine, Universitat Autònoma de Barcelona)
- Ivan Formentini
(Cardiovascular and Metabolism Disease Therapy Area, F. Hoffmann-La Roche Ltd)
- Maria Bobadilla
(Cardiovascular and Metabolism Disease Therapy Area, F. Hoffmann-La Roche Ltd)
- Jacques Mizrahi
(Cardiovascular and Metabolism Disease Therapy Area, F. Hoffmann-La Roche Ltd)
- Alba de Martino
(Histopathology Unit, Spanish National Cancer Research Centre (CNIO))
- Gonzalo Gomez
(Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO))
- David Pisano
(Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO))
- Francisca Mulero
(Molecular Imaging Unit, Spanish National Cancer Research Centre (CNIO))
- Kai C. Wollert
(Molekulare und Translationale Kardiologie, Hans-Borst-Zentrum fuür Herz- und Stammzellforschung, Klinik fuür Kardiologie und Angiologie, Medizinische Hochschule Hannover)
- Fatima Bosch
(Centre of Animal Biotechnology and Gene Therapy (CBATEG), School of Veterinary Medicine, Universitat Autònoma de Barcelona)
- Maria A. Blasco
(Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO))
Abstract
Coronary heart disease is one of the main causes of death in the developed world, and treatment success remains modest, with high mortality rates within 1 year after myocardial infarction (MI). Thus, new therapeutic targets and effective treatments are necessary. Short telomeres are risk factors for age-associated diseases, including heart disease. Here we address the potential of telomerase (Tert) activation in prevention of heart failure after MI in adult mice. We use adeno-associated viruses for cardiac-specific Tert expression. We find that upon MI, hearts expressing Tert show attenuated cardiac dilation, improved ventricular function and smaller infarct scars concomitant with increased mouse survival by 17% compared with controls. Furthermore, Tert treatment results in elongated telomeres, increased numbers of Ki67 and pH3-positive cardiomyocytes and a gene expression switch towards a regeneration signature of neonatal mice. Our work suggests telomerase activation could be a therapeutic strategy to prevent heart failure after MI.
Suggested Citation
Christian Bär & Bruno Bernardes de Jesus & Rosa Serrano & Agueda Tejera & Eduard Ayuso & Veronica Jimenez & Ivan Formentini & Maria Bobadilla & Jacques Mizrahi & Alba de Martino & Gonzalo Gomez & Davi, 2014.
"Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction,"
Nature Communications, Nature, vol. 5(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6863
DOI: 10.1038/ncomms6863
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6863. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.